Page last updated: 2024-08-24

lissamine rhodamine b sulfonyl chloride and Parkinson Disease

lissamine rhodamine b sulfonyl chloride has been researched along with Parkinson Disease in 1 studies

*Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, G; He, Y; Liu, S; Liu, Z; Sun, J; Suo, Y; Wei, N; You, J; Zhao, XE; Zhou, Y; Zhu, S1

Other Studies

1 other study(ies) available for lissamine rhodamine b sulfonyl chloride and Parkinson Disease

ArticleYear
In situ derivatization-ultrasound-assisted dispersive liquid-liquid microextraction for the determination of neurotransmitters in Parkinson's rat brain microdialysates by ultra high performance liquid chromatography-tandem mass spectrometry.
    Journal of chromatography. A, 2016, Aug-05, Volume: 1458

    Topics: Acetonitriles; Animals; Brain Chemistry; Bromobenzenes; Buffers; Catecholamines; Chromatography, High Pressure Liquid; Green Chemistry Technology; Limit of Detection; Liquid Phase Microextraction; Microdialysis; Neurotransmitter Agents; Parkinson Disease; Rats; Rhodamines; Tandem Mass Spectrometry; Time Factors; Ultrasonics

2016